Cardiovascular outcomes and mortality after initiation of canagliflozin: Analyses from the EASEL Study

Cardiovascular outcomes and mortality after initiation of canagliflozin: Analyses from the EASEL Study

Abstract Introduction In the EASEL study of patients with type 2 diabetes and high cardiovascular risk, initiation of sodium glucose co‐transporter 2 inhibitors (SGLT2i) was associated with lower risk of cardiovascular events and mortality and higher risk of below‐knee lower extremity (BKLE) amputat...

Full description

Bibliographic Details
Main Authors: Jacob A. Udell, Zhong Yuan, Patrick Ryan, Toni Rush, Nicholas M. Sicignano, Michael Galitz, Norman Rosenthal
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Endocrinology, Diabetes & Metabolism
Subjects:
major adverse cardiovascular event
sodium glucose co‐transporter 2 inhibitor
type 2 diabetes mellitus
Online Access:https://doi.org/10.1002/edm2.96

Internet

https://doi.org/10.1002/edm2.96

Similar Items